Jim Simons Kronos Bio, Inc. Transaction History
Renaissance Technologies LLC
- $62.3 Billion
- Q1 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,102,326 shares of KRON stock, worth $970,046. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,102,326
Previous 1,171,808
5.93%
Holding current value
$970,046
Previous $1.11 Million
18.87%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding KRON
# of Institutions
47Shares Held
16.6MCall Options Held
51.2KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA1.92MShares$1.69 Million0.0% of portfolio
-
Partners Capital Investment Group, LLP Boston, MA1.45MShares$1.27 Million0.02% of portfolio
-
Alphabet Inc. Mountain View, CA1.44MShares$1.27 Million0.11% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.43MShares$1.25 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.35MShares$1.18 Million0.07% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $50M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...